Literature DB >> 32719203

The importance of intra- and inter-institutional networks for capacity building in severe acute respiratory syndrome coronavirus 2 reverse transcription polymerase chain reaction services: experience from an oncology centre in eastern India.

Deepak Kumar Mishra1, Gaurav Goel2, Neeraj Arora3, Shekhar Krishnan4, Sanjay Bhattacharya1, Purva Mathur5, Kamini Walia6, Mammen Chandy7.   

Abstract

High-throughput, accurate, cost-effective and rapid testing for severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is the need of the hour in face of the global coronavirus disease pandemic. This target is achievable, within a relatively short time through capacity building of reverse transcription polymerase chain reaction (RT-PCR) tests by utilising the strengths of intra and inter institutional networks. These networks act as force multiplier for vital resources which are required for capacity building, namely, leadership, expertise, equipment, space, infection control inputs and human resources. In this article, we report the experience of capacity building for delivery of RT-PCR tests for SARS CoV-2 from a cancer hospital in Eastern India. The relevance, mode of operation and value addition of this essential public health service are discussed in the context of inter departmental collaboration and interaction with other institutes through the existing diagnostic, surveillance and infection control networks. This networking model for service development and delivery could be used by other centres.

Entities:  

Keywords:  Capacity building; coronavirus disease; equipment; human resource; networks; reverse transcription polymerase chain reaction; severe acute respiratory syndrome coronavirus 2

Mesh:

Year:  2020        PMID: 32719203      PMCID: PMC7706412          DOI: 10.4103/ijmm.IJMM_20_255

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  13 in total

1.  Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times.

Authors:  Tamer C Inal; Ozlem Goruroglu Ozturk; Filiz Kibar; Salih Cetiner; Selcuk Matyar; Gulcin Daglioglu; Akgun Yaman
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

2.  Strategic planning to augment the testing capacity for COVID-19 in India.

Authors:  Nivedita Gupta; Tarun Bhatnagar; Kiran Rade; Manoj Murhekar; Raman R Gangakhedkar; Anu Nagar
Journal:  Indian J Med Res       Date:  2020 Feb & Mar       Impact factor: 2.375

Review 3.  The role of the clinical laboratory in the future of health care: lean microbiology.

Authors:  Linoj Samuel; Susan Novak-Weekley
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

4.  Building laboratory capacity to combat disease outbreaks in Africa.

Authors:  Trevor Peter; Mah-Sere Keita; John Nkengasong
Journal:  Afr J Lab Med       Date:  2016-10-27

5.  Strengthening laboratory capacity for detection of respiratory viral pathogens through the Global Health Security Agenda (GHSA) framework.

Authors:  Brett Whitaker; Karen A Alroy; Erica Guthrie; Sarah Schildecker; Susan Hiers; Jill Woodard; S Arunmozhi Balajee
Journal:  Afr J Lab Med       Date:  2019-07-18

6.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

Authors:  Victor M Corman; Olfert Landt; Marco Kaiser; Richard Molenkamp; Adam Meijer; Daniel Kw Chu; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Marie Luisa Schmidt; Daphne Gjc Mulders; Bart L Haagmans; Bas van der Veer; Sharon van den Brink; Lisa Wijsman; Gabriel Goderski; Jean-Louis Romette; Joanna Ellis; Maria Zambon; Malik Peiris; Herman Goossens; Chantal Reusken; Marion Pg Koopmans; Christian Drosten
Journal:  Euro Surveill       Date:  2020-01

7.  Capacity building in response to pandemic influenza threats: Lao PDR case study.

Authors:  Bounlay Phommasack; Ann Moen; Phengta Vongphrachanh; Reiko Tsuyuoka; Nancy Cox; Bouaphanh Khamphaphongphanh; Darouny Phonekeo; Takeshi Kasai; Pakapak Ketmayoon; Hannah Lewis; Bounheuang Kounnavong; Viengphone Khanthamaly; Andrew Corwin
Journal:  Am J Trop Med Hyg       Date:  2012-12       Impact factor: 2.345

8.  Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.

Authors:  Chantal B E M Reusken; Eeva K Broberg; Bart Haagmans; Adam Meijer; Victor M Corman; Anna Papa; Remi Charrel; Christian Drosten; Marion Koopmans; Katrin Leitmeyer
Journal:  Euro Surveill       Date:  2020-02-11

9.  Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020.

Authors:  Regina Konrad; Ute Eberle; Alexandra Dangel; Bianca Treis; Anja Berger; Katja Bengs; Volker Fingerle; Bernhard Liebl; Nikolaus Ackermann; Andreas Sing
Journal:  Euro Surveill       Date:  2020-03

Review 10.  Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis.

Authors:  Devendra T Mourya; Gajanan Sapkal; Pragya D Yadav; Sujeet Kumar M Belani; Anita Shete; Nivedita Gupta
Journal:  Indian J Med Res       Date:  2020 Feb & Mar       Impact factor: 5.274

View more
  1 in total

1.  Assessment of COVID-19 Molecular Testing Capacity in Jordan: A Cross-Sectional Study at the Country Level.

Authors:  Bara'a Qaqish; Malik Sallam; Maysa Al-Khateeb; Erik Reisdorf; Azmi Mahafzah
Journal:  Diagnostics (Basel)       Date:  2022-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.